A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myelomaa prospective randomised phase III study

Autor:	M VANAGTHOVEN, C SEGEREN, I BUIJT, C UYLDEGROOT, B VANDERHOLT, H LOKHORST, P SONNEVELD
Rok vydání:	2004
Předmět:	Cancer Research Oncology
Zdroj:	European Journal of Cancer. 40:1159-1169
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(04)00128-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::62090b0caf6f041bffdcdcbe018624ce https://doi.org/10.1016/s0959-8049(04)00128-5 Zobrazit plný text záznamu Full Text from ScienceDirect